Frederic Boned - 12 Feb 2025 Form 4/A - Amendment Insider Report for BALCHEM CORP (BCPC)

Role
SVP/GM, Human Nutri. & Health
Signature
/s/ Travis Larsen, Attorney in Fact for Frederic Boned
Issuer symbol
BCPC
Transactions as of
12 Feb 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
11 Apr 2025, 18:07:28 UTC
Date Of Original Report
14 Feb 2025
Previous filing
12 Feb 2024
Next filing
03 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +1,580 +31% $0.000000 6,730 12 Feb 2025 Direct F1
holding BCPC Common Stock 312 12 Feb 2025 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +5,200 $0.000000 5,200 12 Feb 2025 Common Stock 5,200 $159.18 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person ratably over a 3 year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Options vest 20% Year 1; 40% Year 2: and 40% Year 3.

Remarks:

This Form 4/A amends and restates the original Form 4 filed on February 14, 2025, which inadvertently noted the vesting period for restricted stock as 3 years from the grant date, instead of a ratable vesting over a 3-year period.